ACA
DXCM icon

Atlas Capital Advisors’s DexCom DXCM Stock Holding History

Atlas Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$15.6K – 991
2024
Q4 		$15.6K Buy
+200
New +$14.8K ﹤0.01% 740
2024
Q3 		– Sell
-200
Closed -$22.7K – 922
2024
Q2 		$22.7K Buy
+200
New +$25.3K ﹤0.01% 682
2024
Q1 		– Sell
-200
Closed -$24.8K – 911
2023
Q4 		$24.8K Hold
200
– – ﹤0.01% 673
2023
Q3 		$18.7K Hold
200
– – ﹤0.01% 642
2023
Q2 		$25.7K Hold
200
– – ﹤0.01% 649
2023
Q1 		$23.2K Hold
200
– – ﹤0.01% 663
2022
Q4 		$22.6K Hold
200
– – ﹤0.01% 652
2022
Q3 		$16.1K Sell
200
-244
-55% -$20.7K ﹤0.01% 671
2022
Q2 		$33.1K Buy
+444
New +$40.5K 0.01% 615

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Atlas Capital Advisors's DXCM Position: Q1 2025 in Review

Atlas Capital Advisors sold out of DexCom (DXCM) in Q1 2025, closing a stake of 200 shares — an estimated $15.6K sold.

Atlas Capital Advisors first reported a position in DXCM in Q2 2022 and held it in 9 quarters. The position peaked at $33.1K in Q2 2022. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Atlas Capital Advisors reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Atlas Capital Advisors sold 200 DexCom shares in Q1 2025, an estimated $15.6K.
  • Atlas Capital Advisors first reported a position in DexCom in Q2 2022 and held it in 9 quarters.
  • Atlas Capital Advisors's DexCom position peaked at $33.1K in Q2 2022.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Atlas Capital Advisors's 13F filing for Q1 2025, filed 12 May 2025.